Loss-of-Function Mutations in NR4A2 Cause Dopa-Responsive Dystonia Parkinsonism

Area of Science:

• Neurogenetics
• Molecular Neurology

Background:

• The genetic basis of dystonia syndromes is increasingly understood, yet the etiology of some dystonia parkinsonism cases remains elusive.
• Identifying novel genetic factors is crucial for understanding the pathogenesis of complex neurological disorders.

Observation:

• Two families presented with early-onset dystonia parkinsonism, preceded by mild childhood intellectual disability.
• Neuroimaging revealed normal brain MRI but suggested dopaminergic deficits via DATscan.
• Exome sequencing identified frameshift mutations in the NR4A2 gene (nuclear receptor subfamily 4 group A member 2) in both affected individuals.

Findings:

• Loss-of-function mutations in NR4A2 are associated with a distinct phenotype of early-onset dystonia parkinsonism.
• The identified mutations, c.326dupA and c.881dupA in NR4A2, lead to haploinsufficiency.
• Clinical presentation can include a significant delay between initial neurodevelopmental symptoms and the onset of movement disorders.

Implications:

• NR4A2 mutations should be considered in the differential diagnosis of unexplained dystonia parkinsonism.
• This study expands the genotypic spectrum associated with NR4A2, linking it to movement disorders.
• Understanding the role of NR4A2 in neuronal function may offer new therapeutic targets for dystonia and related parkinsonian syndromes.